Real-world outcomes of sipuleucel-T treatment in PROCEED, a prospective registry of men with metastatic castration-resistant prostate cancer. Read more about Real-world outcomes of sipuleucel-T treatment in PROCEED, a prospective registry of men with metastatic castration-resistant prostate cancer.
Frequency and outcomes of brain metastases in patients with HER2-mutant lung cancers. Read more about Frequency and outcomes of brain metastases in patients with HER2-mutant lung cancers.
Second-line chemotherapy in advanced biliary cancers: A retrospective, multicenter analysis of outcomes. Read more about Second-line chemotherapy in advanced biliary cancers: A retrospective, multicenter analysis of outcomes.
Targeted therapy for colorectal cancer metastases: A review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer. Read more about Targeted therapy for colorectal cancer metastases: A review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer.
Predictors of skeletal-related events and mortality in men with metastatic, castration-resistant prostate cancer: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Read more about Predictors of skeletal-related events and mortality in men with metastatic, castration-resistant prostate cancer: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
Provocative questions in osteosarcoma basic and translational biology: A report from the Children's Oncology Group. Read more about Provocative questions in osteosarcoma basic and translational biology: A report from the Children's Oncology Group.
Food insecurity screening: A missing piece in cancer management. Read more about Food insecurity screening: A missing piece in cancer management.
Conservative management of low-risk prostate cancer among young versus older men in the United States: Trends and outcomes from a novel national database. Read more about Conservative management of low-risk prostate cancer among young versus older men in the United States: Trends and outcomes from a novel national database.
Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer. Read more about Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer.
